Prior research indicated that CRP was generally elevated in breast cancer patients, suggesting its crucial role in the pathophysiology of inflammation in patients with metastatic breast cancer, which is associated with higher mortality [32,33]. The gene discussed is CRP; the disease is breast carcinoma.